It is best to discuss this with your cardiologist. Belviq can affect cardiovascular function. Your cardiologist should be able to advise you if it is okay for you.
Lorcaserin (Includes Belviq) ↔ Bradycardia
Moderate Potential Hazard, Moderate plausibility
Applies to: Heart Block, Sinus Node Dysfunction
Lorcaserin may decrease heart rate. In clinical trials of at least one year duration, the mean decrease in heart rate was 1.2 beats per minute (bpm) in lorcaserin-treated and 0.4 bpm in placebo-treated patients without diabetes, and 2.0 bpm in lorcaserin-treated and 0.4 bpm in placebo-treated patients with type 2 diabetes. The incidence of heart rate less than 50 bpm was 5.3% in lorcaserin-treated and 3.2% in placebo-treated patients without diabetes, and 3.6% in lorcaserin-treated and 2.0% in placebo-treated patients with type 2 diabetes. In the combined population, adverse reactions of bradycardia occurred in 0.3% of lorcaserin-treated and 0.1% of placebo-treated patients. Therapy with lorcaserin should be administered cautiously in patients with bradycardia or a history of heart block greater than first degree.
- Belviq Information for Consumers
- Belviq Information for Healthcare Professionals (includes dosage details)
- Side Effects of Belviq (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Updated 7 Oct 2009 • 1 answer
Atrial Fibrillation - How many times can cardioversion be performed for A Fib and within what period
Updated 18 Oct 2009 • 1 answer
Updated 5 Aug 2013 • 5 answers
Updated 10 Dec 2013 • 1 answer
Updated 23 Dec 2015 • 1 answer